FDA 483 - The Flex Company - February 03, 2023

The Flex Company, a medical device manufacturer in Venice, CA, was inspected by the FDA from January 31 to February 3, 2023. The inspection revealed two observations related to inadequate procedures. Specifically, the firm failed to adequately establish procedures for design transfer and for corrective and preventive actions.